InVivoMAb anti-human CD2
BE0354
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human CD2
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDCB.219
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2b
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Erben U, Pawlowski NN, Heimesaat MM, et al. Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model. Eur J Microbiol Immunol (Bp). 2015,5(4):306-15. doi: 10.1556/1886.2015.00040Read this paper
- Erben U, Pawlowski NN, Doerfel K, et al. Targeting human CD2 by the monoclonal antibody CB.219 reduces intestinal inflammation in a humanized transfer colitis model. Clin Immunol. 2015,157(1):16-25. doi: 10.1016/j.clim.2015.01.004Read this paper
